IMHO, this is a near impossible task. The BOD already owned most...

IMHO, this is a near impossible task. The BOD already owned most part of the company and as I said many months ago. The value propositions of the BOD has misaligned with the loyal shareholders, they could easily accept a lowball 20mil or 50mil offer and walk off.

Mark from pharmaceutical arm may just get a high profile position in the new company and $1m per annual annum salary if takeover ever happens. Everyone wins within the team and the one who paid loyalty tax lost.